Rubedo Life Sciences Expands Leadership Team with Ali Siam as Chief Business Officer and Ofir Moreno

SUNNYVALE, Calif.--(BUSINESS WIRE)--#aging--Rubedo Life Sciences, a biopharmaceutical company pioneering first-in-class therapies for chronic age-related diseases targeting the senescent cells that drive cellular aging, today announced the appointment of veteran biotech executives Ali Siam as Chief Business Officer...

Related Keywords

Boston ,Massachusetts ,United States ,Boston College ,Harvard University ,Northeastern University ,Marco Quarta ,Yoshito Kishi ,Amgen ,Bayer Ag ,Corvas International ,Boston Scientific ,Cornell University ,Rubedo Life Sciences ,Founder Of Rubedo Life Sciences ,Johnson ,Ali Siam ,Chief Business Officer ,Ofir Moreno ,Senior Vice President ,Chief Executive Officer ,Rubedo Life ,Market Access ,Infectious Disease ,Mechanical Engineering ,Drug Discovery ,Pharmaceutical Sciences ,Norganic Chemistry ,Professor Yoshito Kishi ,Life Sciences ,